Impact of serial measurements of tricuspid annular plane systolic excursion on mortality and morbidity after heart transplantation
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Impact of serial measurements of tricuspid annular plane systolic excursion on mortality and morbidity after heart transplantation. / Vishram-Nielsen, Julie K.K.; Nelson, Lærke M.; Fan, Chun Po; Foroutan, Farid; Gustafsson, Finn; Billia, Filio; Ross, Heather J.; Alba, Ana Carolina.
In: Clinical Transplantation, Vol. 36, No. 6, e14662, 2022.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Impact of serial measurements of tricuspid annular plane systolic excursion on mortality and morbidity after heart transplantation
AU - Vishram-Nielsen, Julie K.K.
AU - Nelson, Lærke M.
AU - Fan, Chun Po
AU - Foroutan, Farid
AU - Gustafsson, Finn
AU - Billia, Filio
AU - Ross, Heather J.
AU - Alba, Ana Carolina
N1 - Publisher Copyright: © 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
PY - 2022
Y1 - 2022
N2 - The impact of right ventricular (RV) dysfunction on long-term post-HTx outcomes remains uncertain. We assessed the impact of serial measurements of Tricuspid Annular Plane Systolic Excursion (TAPSE) on post-HTx mortality and morbidity. This two-center retrospective cohort study included consecutive adult HTx recipients (2000–2017). We used multivariable extended hazard regression models to evaluate the association between TAPSE and left ventricular ejection fraction (LVEF), entered as time-dependent variables, and all-cause mortality, cardiac allograft vasculopathy (CAV), acute cellular rejection (ACR), and chronic kidney disease (CKD). TAPSE was modelled using cubic splines. We included 485 HTx recipients (9461 TAPSE measurements), median (25th- 75th percentile) 19 (10–27) mm; median age was 52 (41–59) years, and 71.3% were male. During a follow-up of 6.7 (3.0–10.8) years, 92 patients died, 225 had ACR >2R, 234 CAV, and 91 CKD. By multivariable analysis, for each 1-mm decrease in patients with a TAPSE value <15mm, mortality increased by 22% (P<.001). For the average HTx recipient with a TAPSE of 15mm, 10mm, and 6mm, 1-year mortality was 3%, 7%, and 17%, and 5-year mortality was 8%, 20%, and 43%, respectively. Reduced TAPSE was significantly associated with increased CAV but notACR and CKD. A decrease in TAPSE below 15mm represents clinically significant graft dysfunction, warranting close monitoring.
AB - The impact of right ventricular (RV) dysfunction on long-term post-HTx outcomes remains uncertain. We assessed the impact of serial measurements of Tricuspid Annular Plane Systolic Excursion (TAPSE) on post-HTx mortality and morbidity. This two-center retrospective cohort study included consecutive adult HTx recipients (2000–2017). We used multivariable extended hazard regression models to evaluate the association between TAPSE and left ventricular ejection fraction (LVEF), entered as time-dependent variables, and all-cause mortality, cardiac allograft vasculopathy (CAV), acute cellular rejection (ACR), and chronic kidney disease (CKD). TAPSE was modelled using cubic splines. We included 485 HTx recipients (9461 TAPSE measurements), median (25th- 75th percentile) 19 (10–27) mm; median age was 52 (41–59) years, and 71.3% were male. During a follow-up of 6.7 (3.0–10.8) years, 92 patients died, 225 had ACR >2R, 234 CAV, and 91 CKD. By multivariable analysis, for each 1-mm decrease in patients with a TAPSE value <15mm, mortality increased by 22% (P<.001). For the average HTx recipient with a TAPSE of 15mm, 10mm, and 6mm, 1-year mortality was 3%, 7%, and 17%, and 5-year mortality was 8%, 20%, and 43%, respectively. Reduced TAPSE was significantly associated with increased CAV but notACR and CKD. A decrease in TAPSE below 15mm represents clinically significant graft dysfunction, warranting close monitoring.
KW - heart transplantation
KW - morbidity
KW - mortality
KW - tricuspid annular plane systolic excursion
U2 - 10.1111/ctr.14662
DO - 10.1111/ctr.14662
M3 - Journal article
C2 - 35368127
AN - SCOPUS:85128870105
VL - 36
JO - Clinical Transplantation
JF - Clinical Transplantation
SN - 0902-0063
IS - 6
M1 - e14662
ER -
ID: 310963678